324 results on '"Ting, Naitee"'
Search Results
2. Introduction to Special Issue on Leveraging External Data to Improve Trial Efficiency
3. Estimation of Discrete Survival Function through Modeling Diagnostic Accuracy for Mismeasured Outcome Data
4. Approaches to Combining Phase II Proof-of-Concept and Dose-Finding Trials
5. Average Response over Time as Estimand: An Alternative Implementation of the While on Treatment Strategy
6. Proof of Concept: Drug Selection? Or Dose Selection? Thoughts on Multiplicity Issues
7. Can the Concept Be Proven?
8. Phase II Dose Finding
9. Concept of Alpha
10. Data Analysis for Dose-Ranging Trials with Continuous Outcome
11. Analysis of a Proof of Concept Study
12. Risks of Inconclusiveness
13. Design of Dose-Ranging Trials
14. Combining Proof of Concept and Dose-Ranging Trials
15. Design a Proof of Concept Trial
16. Confirmation and Exploration
17. Introduction
18. Bayesian Approach
19. Overview of Phase III Clinical Trials
20. Data Analysis of Dose-Ranging Trials for Binary Outcomes
21. Introduction to Special Issue on ‘Statistical Methods for Cancer Immunotherapy’
22. Pharmacokinetics-Guided Dose Allocation in Comparison with Binary Dose Spacing
23. Response to letter to the editor – comment on “emerging insights and commentaries – MMRM vs LOCF by Naitee Ting”
24. A Simple and Efficient Statistical Approach for Designing an Early Phase II Clinical Trial: Ordinal Linear Contrast Test
25. Evaluation of a Confidence Interval Approach for Relative Agreement in a Crossed Three-Way Random Effects Model
26. A Cautionary Note When a Dose-Ranging Study is Used for Proving the Concept
27. Sample Size Allocation in a Dose-Ranging Trial Combined with PoC
28. How to select the initial dose for a pediatric study?
29. Statistical Interactions in a Clinical Trial
30. How to implement the ‘one patient, one vote’ principle under the framework of estimand
31. Confidence intervals for discrete data in clinical research By VivekPradhan, Ashis K.Gangopadhyay, Sandeep M.Menon, CynthiaBasu, TathagataBanerjee, Chapman and Hall. 2021. pp. 226. $119.95. (hbk). ISBN: 978‐1138048980
32. Emerging insights and commentaries – MMRM vs LOCF
33. General Considerations in Dose–Response Study Designs
34. Introduction and New Drug Development Process
35. Partitioning Tests in Dose–Response Studies with Binary Outcomes
36. How to select the initial dose for a pediatric study?
37. A Prospective, Randomized, Open-Label Study to Evaluate Two Management Strategies for Gastrointestinal Symptoms in Patients Newly on Treatment with Dabigatran
38. Consistency Based Multiplicity Adjustment Approach—Multiple Doses in Phase III Studies
39. A Simple and Efficient Statistical Approach for Designing an Early Phase II Clinical Trial: Ordinal Linear Contrast Test
40. Introduction
41. Bayesian Approach
42. Risks of Inconclusiveness
43. Combining Proof of Concept and Dose-Ranging Trials
44. Data Analysis of Dose-Ranging Trials for Binary Outcomes
45. Data Analysis for Dose-Ranging Trials with Continuous Outcome
46. Design a Proof of Concept Trial
47. Phase II Clinical Development of New Drugs
48. Analysis of a Proof of Concept Study
49. Overview of Phase III Clinical Trials
50. Concept of Alpha
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.